Victor de Ledinghen Selected Research

Victor de Ledinghen Research Topics

Disease

29	Fibrosis (Cirrhosis) 01/2023 - 11/2004
12	Infections 12/2022 - 03/2006
9	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019 - 02/2006
7	Non-alcoholic Fatty Liver Disease 08/2022 - 02/2006
6	Liver Diseases (Liver Disease) 12/2022 - 07/2012
6	Chronic Hepatitis C 07/2015 - 08/2005
3	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2021
3	Hepatitis C 01/2019 - 10/2016
2	Fatty Liver 10/2023 - 11/2010
2	Neoplasms (Cancer) 11/2021 - 01/2021
2	Liver Neoplasms (Liver Cancer) 08/2021 - 04/2014
2	Disease Progression 01/2021 - 06/2018
2	Hepatitis 01/2016 - 11/2006
2	Inflammation (Inflammations) 05/2011 - 01/2009
1	HIV Infections (HIV Infection) 11/2021
1	Type 2 Diabetes Mellitus (MODY) 08/2021
1	Autoimmune Hepatitis 01/2021
1	Hepatolenticular Degeneration (Wilson's Disease) 01/2020
1	End Stage Liver Disease 01/2020
1	Coinfection 01/2019
1	Obesity 01/2019
1	Hyperferritinemia 11/2018
1	Myalgia 06/2018
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 06/2018
1	Alcoholic Hepatitis 01/2018
1	Chronic Renal Insufficiency 01/2018
1	Kidney Diseases (Kidney Disease) 01/2015
1	Chronic Hepatitis B 11/2014
1	Insulin Resistance 05/2011
1	Atrophy 11/2006
1	Gastritis 11/2006

Drug/Important Bio-Agent (IBA)

12	Antiviral Agents (Antivirals)IBA 12/2022 - 01/2016
7	Biomarkers (Surrogate Marker)IBA 11/2014 - 02/2006
5	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2018 - 01/2009
5	Ribavirin (Virazole)FDA LinkGeneric 07/2015 - 11/2004
4	glecaprevir and pibrentasvirIBA 12/2022 - 01/2018
4	Transaminases (Aminotransferases)IBA 01/2019 - 02/2006
3	Alanine Transaminase (SGPT)IBA 01/2019 - 01/2009
2	Protease Inhibitors (Protease Inhibitor)IBA 12/2022 - 04/2015
2	AlbuminsIBA 08/2022 - 01/2022
2	Prothrombin (Factor II)IBA 08/2022 - 01/2018
2	TransferasesIBA 08/2021 - 01/2017
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2019 - 01/2015
2	grazoprevirIBA 01/2018 - 01/2018
2	F 4 (F-4)IBA 01/2018 - 11/2015
2	elbasvirIBA 01/2018 - 01/2018
2	SofosbuvirIBA 10/2016 - 10/2016
2	InterferonsIBA 04/2015 - 11/2004
1	Proteins (Proteins, Gene)FDA Link 08/2021
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 08/2021
1	HaptoglobinsIBA 08/2021
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 08/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	CopperIBA 01/2020
1	Illicit Drugs (Recreational Drugs)IBA 09/2019
1	Coffee FDA Link 01/2019
1	SolutionsIBA 01/2019
1	Transferrin (beta 2 Transferrin)IBA 11/2018
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 06/2018
1	BezafibrateIBA 06/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	BilirubinIBA 01/2018
1	glecaprevirIBA 01/2018
1	daclatasvirIBA 10/2016
1	sofosbuvir drug combination ledipasvirIBA 04/2015
1	Surface Antigens (Surface Antigen)IBA 01/2015
1	Dihydrotachysterol (AT 10)IBA 04/2014
1	Erythropoietin FDA Link 09/2013
1	CarbohydratesIBA 01/2013
1	deleobuvirIBA 07/2012
1	N 30IBA 07/2012
1	AcidsIBA 05/2011
1	A-factor (Streptomyces)IBA 11/2010
1	Peptides (Polypeptides)IBA 11/2006
1	Urea (Carbamide)FDA LinkGeneric 11/2006
1	LeptinIBA 11/2006
1	GhrelinIBA 11/2006
1	Interferon-alpha (Interferon Alfa)IBA 08/2005

Therapy/Procedure

7	Therapeutics 12/2022 - 08/2005
6	Liver Transplantation 01/2023 - 10/2016
2	Aftercare (After-Treatment) 12/2022 - 01/2022
1	Drug Therapy (Chemotherapy) 10/2023
1	Opiate Substitution Treatment 10/2020
1	Renal Dialysis (Hemodialysis) 01/2018
1	Glycemic Control 05/2011
1	Blood Transfusion (Blood Transfusions) 03/2006